메뉴 건너뛰기




Volumn 53, Issue 11, 2006, Pages 1074-1077

Drug transformation: Advances in drug delivery systems;La transformation des médicaments par de nouveaux vecteurs

Author keywords

[No Author keywords available]

Indexed keywords

AEROLEF; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANESTHETIC AGENT; ANTIINFECTIVE AGENT; CREMAPHOR; DOXORUBICIN; DRUG CARRIER; DRUG VEHICLE; ELA MAX TOPICAL ANESTHETIC; EMLA; FENTANYL; LIDOCAINE; LIPOSOME; MACROGOL; MEPIVACAINE; MORPHINE SULFATE; PRILOCAINE; PROPOFOL; SOYBEAN OIL; UNCLASSIFIED DRUG;

EID: 33751033801     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03022873     Document Type: Editorial
Times cited : (9)

References (22)
  • 1
    • 0031696687 scopus 로고    scopus 로고
    • Formulation-dependent brain and lung distribution kinetics of propofol in rats
    • Dutta S, Ebling WF. Formulation-dependent brain and lung distribution kinetics of propofol in rats. Anesthesiology 1998; 89: 678-85.
    • (1998) Anesthesiology , vol.89 , pp. 678-685
    • Dutta, S.1    Ebling, W.F.2
  • 2
    • 26244449630 scopus 로고    scopus 로고
    • Propofol: The challenges of formulation
    • Baker MT, Naguib M. Propofol: the challenges of formulation. Anesthesiology 2005; 103: 860-76.
    • (2005) Anesthesiology , vol.103 , pp. 860-876
    • Baker, M.T.1    Naguib, M.2
  • 3
    • 0018885763 scopus 로고
    • Suspected anaphylactic reaction to Cremophor EL
    • Dye D, Watkins J. Suspected anaphylactic reaction to Cremophor EL. Br Med J 1980; 280: 1353.
    • (1980) Br Med J , vol.280 , pp. 1353
    • Dye, D.1    Watkins, J.2
  • 4
    • 0018837119 scopus 로고
    • Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR)
    • Huttel MS, Schou Olesen A, Stoffersen E. Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR). Br J Anaesth 1980; 52: 77-90.
    • (1980) Br J Anaesth , vol.52 , pp. 77-90
    • Huttel, M.S.1    Schou Olesen, A.2    Stoffersen, E.3
  • 5
    • 0030795053 scopus 로고    scopus 로고
    • Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulation
    • Dutta S, Matsumoto Y, Ebling WF. Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulation. J Pharm Sci 1997; 86: 967-9.
    • (1997) J Pharm Sci , vol.86 , pp. 967-979
    • Dutta, S.1    Matsumoto, Y.2    Ebling, W.F.3
  • 6
    • 0034527359 scopus 로고    scopus 로고
    • The recent development of propofol (DIPRIVAN)
    • Thompson KA, Goodale DB. The recent development of propofol (DIPRIVAN). Intensive Care Med 2000; 26(suppl 4): S400-4.
    • (2000) Intensive Care Med , vol.26 , Issue.SUPPL. 4
    • Thompson, K.A.1    Goodale, D.B.2
  • 7
    • 0037275061 scopus 로고    scopus 로고
    • Colloidal drug carriers: Achievements and perspectives
    • Barratt G. Colloidal drug carriers: achievements and perspectives. Cell Mol Life Sci 2003; 60: 21-37.
    • (2003) Cell Mol Life Sci , vol.60 , pp. 21-37
    • Barratt, G.1
  • 8
    • 85012373035 scopus 로고
    • Diffision of univalent ions across the lamellae of swollen phospho-lipids
    • Bangham AD, Standish MM, Watkins JC. Diffision of univalent ions across the lamellae of swollen phospho-lipids. J Mol Biol 1965; 13: 238-52.
    • (1965) J Mol Biol , vol.13 , pp. 238-252
    • Bangham, A.D.1    Standish, M.M.2    Watkins, J.C.3
  • 9
    • 33751037734 scopus 로고    scopus 로고
    • Liposomal formulations of prilocaine, lidocaine and mepivacaine prolong analgesic duration
    • Cereda CM, Bruschini G, de Araújo DR, de Paula E. Liposomal formulations of prilocaine, lidocaine and mepivacaine prolong analgesic duration. Can J Anesth, 2006; 53: 1092-7.
    • (2006) Can J Anesth , vol.53 , pp. 1092-1097
    • Cereda, C.M.1    Bruschini, G.2    de Araújo, D.R.3    de Paula, E.4
  • 10
    • 25444475497 scopus 로고    scopus 로고
    • Topical anesthetics for dermal instrumentation: A systematic review of randomized, controlled trials
    • Eidelman A, Weiss JM, Lau J, Carr DB. Topical anesthetics for dermal instrumentation: a systematic review of randomized, controlled trials. Ann Emerg Med 2003; 46: 343-51.
    • (2003) Ann Emerg Med , vol.46 , pp. 343-351
    • Eidelman, A.1    Weiss, J.M.2    Lau, J.3    Carr, D.B.4
  • 11
    • 16244387649 scopus 로고    scopus 로고
    • Pegylated liposomal doxorubicin: Optimizing the dosing schedule in ovarian cancer
    • Rose PG. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer. Oncologist 2005; 10: 205-14.
    • (2005) Oncologist , vol.10 , pp. 205-214
    • Rose, P.G.1
  • 13
    • 0032991693 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis
    • 42-8; discussion
    • Meyerhoff A. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999; 28: 42-8; discussion 49-51.
    • (1999) Clin Infect Dis , vol.28 , pp. 49-51
    • Meyerhoff, A.1
  • 14
    • 17844380498 scopus 로고    scopus 로고
    • Pegylation: A novel process for modifying pharmacokinetics
    • Harris JM, Martin NE, Modi M. Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 2001; 40: 539-51.
    • (2001) Clin Pharmacokinet , vol.40 , pp. 539-551
    • Harris, J.M.1    Martin, N.E.2    Modi, M.3
  • 15
    • 0033928514 scopus 로고    scopus 로고
    • Controlled-release, pegylation, liposomal formulations: New mechanisms in the delivery of injectable drugs
    • Reddy KR. Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs. Ann Pharmacother 2000; 34: 915-23.
    • (2000) Ann Pharmacother , vol.34 , pp. 915-923
    • Reddy, K.R.1
  • 17
    • 24744443165 scopus 로고    scopus 로고
    • Nanotechnology blooms, at last (Review)
    • Gordon EM, Hall FL. Nanotechnology blooms, at last (Review). Oncol Rep 2005; 13: 1003-7.
    • (2005) Oncol Rep , vol.13 , pp. 1003-1007
    • Gordon, E.M.1    Hall, F.L.2
  • 18
    • 13844297094 scopus 로고    scopus 로고
    • The impact of nanobiotechnology on the development of new drug delivery systems
    • Kayser O, Lemke A, Hernandez-Trejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol 2005; 6: 3-5.
    • (2005) Curr Pharm Biotechnol , vol.6 , pp. 3-5
    • Kayser, O.1    Lemke, A.2    Hernandez-Trejo, N.3
  • 19
    • 18944403564 scopus 로고    scopus 로고
    • The rise and rise of drug delivery
    • Rosen H, Abribat T. The rise and rise of drug delivery. Nat Rev Drug Discov 2005; 4: 381-5.
    • (2005) Nat Rev Drug Discov , vol.4 , pp. 381-385
    • Rosen, H.1    Abribat, T.2
  • 20
    • 4344677173 scopus 로고    scopus 로고
    • Emerging techniques for postoperative analgesia in orthopedic surgery
    • Viscusi ER. Emerging techniques for postoperative analgesia in orthopedic surgery. Am J Orthop 2004; 33: 13-6.
    • (2004) Am J Orthop , vol.33 , pp. 13-16
    • Viscusi, E.R.1
  • 21
    • 33748933965 scopus 로고    scopus 로고
    • Self-titrated aerosolized liposome-encapsulated fentanyl results in rapid onset and sustained analgesia following ACL knee surgery
    • (abstract)
    • Chan V, Valle-Leutri F, Clark J, Rossiter-Rooney M. Self-titrated aerosolized liposome-encapsulated fentanyl results in rapid onset and sustained analgesia following ACL knee surgery. Anesthesiology 2004; 101: A77 (abstract).
    • (2004) Anesthesiology , vol.101
    • Chan, V.1    Valle-Leutri, F.2    Clark, J.3    Rossiter-Rooney, M.4
  • 22
    • 33744955387 scopus 로고    scopus 로고
    • Preparation and anesthetic properties of propofol microemulsions in rats
    • Morey TE, Modell JH, Shekhawat D, et al. Preparation and anesthetic properties of propofol microemulsions in rats. Anesthesiology 2006; 104: 1184-90.
    • (2006) Anesthesiology , vol.104 , pp. 1184-1190
    • Morey, T.E.1    Modell, J.H.2    Shekhawat, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.